Fibromyalgia Trial, Recruiting NCT07327775 Sponsor: Sultan 1. Murat State Hospital Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07327775
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 18 and 50 years old
  • You have been diagnosed with Fibromyalgia Syndrome (a condition causing widespread pain) based on 2016 American College of Rheumatology guidelines
  • You have one or more children between the ages of 6 and 17 — either children who have been diagnosed with ADHD (Attention Deficit/Hyperactivity Disorder), or children who have no psychiatric diagnoses
  • You are able to read and write

Who may not be able to join:

  • You are currently taking regular medication specifically to treat Fibromyalgia Syndrome
  • You currently have an active mental health condition or are taking any medication for a psychiatric disorder
  • You have a history of an infectious disease, a long-term inflammatory condition, or any form of cancer
  • You are currently pregnant or breastfeeding
  • You have a condition affecting your brain or nervous system, such as a history of stroke or multiple sclerosis
  • You have a serious ongoing health condition that may affect your quality of life, such as heart failure, kidney disease, liver disease, lung disease, poorly controlled diabetes, or problems with blood circulation (confirm with trial site)
  • You have a thyroid condition, either an underactive or overactive thyroid
  • You have a current problem with substance misuse or alcohol misuse
  • You are unable to cooperate during the clinical assessment process

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: İbrahim Tiryaki, MD, Sultan 1. Murat State Hospital

Phone: +90 537 651 03 85

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sultan 1. Murat State Hospital
Registry
ClinicalTrials.gov
Start date
26 December 2025
Est. completion
30 April 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

pain severity; quality of life and functional status; level of central sensitization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov